Global Pharmaceuticals & Biotech Breakout Stocks

Exelixis

Market Cap: US$12.4b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

3SBio

Market Cap: HK$34.2b

An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.

ACADIA Pharmaceuticals

Market Cap: US$3.7b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

SanBio

Market Cap: JP¥215.3b

Develops, produces, and sells regenerative cell medicines for the central nervous system.

GI Innovation

Market Cap: ₩1.1t

A bio-venture company, engages in the research and development of protein new drugs.

D&D Pharmatech

Market Cap: ₩966.9b

A clinical-stage biotech company, develops medicines in South Korea and the United States.

Qianjiang Yongan Pharmaceutical

Market Cap: CN¥4.5b

Qianjiang Yongan Pharmaceutical Co., Ltd.

Harbin Medisan Pharmaceutical

Market Cap: CN¥4.4b

Engages in the research, development, production, and sale of pharmaceutical product and medical devices in China.

Suven Life Sciences

Market Cap: ₹45.4b

A clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally.

Viva Biotech Holdings

Market Cap: HK$3.7b

An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.

Cereno Scientific

Market Cap: SEK 3.3b

A clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases worldwide.

Cidara Therapeutics

Market Cap: US$330.7m

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

Qurient

Market Cap: ₩439.1b

A biotech company, engages in the research and development of drugs to address unmet medical needs in Korea and internationally.

Antengene

Market Cap: HK$2.3b

A biopharmaceutical company, develops novel oncology therapies in Greater China and internationally.

IOL Chemicals and Pharmaceuticals

Market Cap: ₹23.9b

Manufactures and sells pharmaceutical and chemical products in India and internationally.

NervGen Pharma

Market Cap: CA$332.2m

A clinical-stage biotech company together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage.

Nuvectis Pharma

Market Cap: US$233.3m

A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.

Bio SolutionLtd

Market Cap: ₩268.3b

Develops, manufactures, and sells cell therapy products worldwide.

Fennec Pharmaceuticals

Market Cap: US$188.9m

Operates as a commercial stage biopharmaceutical company in the United States.

Pyridam Farma

Market Cap: Rp2.8t

Engages in the development, production, and trading of pharmaceuticals primarily in Indonesia.

GeneOne Life Science

Market Cap: ₩212.3b

A biopharmaceutical company, engages in the research, development, and contract manufacturing of nucleic acid-based biopharmaceuticals.

Zhaoke Ophthalmology

Market Cap: HK$1.2b

An ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People’s Republic of China, South Korea, and Hong Kong.

Dicot Pharma

Market Cap: SEK 914.3m

Engages in the development of pharmaceutical products in Sweden.

Lytix Biopharma

Market Cap: NOK 539.3m

A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.

MINAPHARM Pharmaceuticals

Market Cap: ج.م2.4b

Produces medicines, medical and dental supplies, and dietary supplements in Egypt and internationally.

Kidswell Bio

Market Cap: JP¥6.8b

Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.

LianBio

Market Cap: US$41.1m

A biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries.

Xintela

Market Cap: SEK 326.2m

A biopharma company, develops medical products in the field of stem cell therapy and targeted cancer therapy.

Regent Pacific Group

Market Cap: HK$262.7m

An investment holding company, holds investments in the healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific.

NeuroSense Therapeutics

Market Cap: US$31.7m

A clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally.

Annexin Pharmaceuticals

Market Cap: SEK 279.4m

A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.

SLS BIO

Market Cap: ₩36.7b

Develops diagnostic technologies in South Korea.

AcuCort

Market Cap: SEK 207.6m

Develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions.

May & Baker Nigeria

Market Cap: ₦23.3b

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.

PreveCeutical Medical

Market Cap: CA$17.0m

A health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.

Otsuka Pakistan

Market Cap: PK₨3.4b

Manufactures, markets, and distributes intravenous infusions in Pakistan and Afghanistan.